UPDATE: Oppenheimer Starts PROLOR Biotech (PBTH) at Outperform; Opportunity in Therapeutic Proteins
Go back to UPDATE: Oppenheimer Starts PROLOR Biotech (PBTH) at Outperform; Opportunity in Therapeutic Proteins| Merck & Co. (NYSE: MRK) | Delayed: 135.55 +2.63 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $132.92 | 52 Week High | $65.46 | |||
| Open | $133.86 | 52 Week Low | $47.97 | |||
| Day High | $135.68 | P/E | 92.21 | |||
| Day Low | $133.06 | EPS | $1.47 | |||
| Volume | 8,894,758 | |||||
| PROLOR Biotech, Inc. (NYSE: PBTH) | Delayed: 8.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.23 | 52 Week High | $8.59 | |||
| Open | $8.23 | 52 Week Low | $4.25 | |||
| Day High | $8.23 | P/E | N/A | |||
| Day Low | $8.23 | EPS | $-0.39 | |||
| Volume | 1,183 | |||||
